{"ticker": {"uuid": "4c18a1c6-95a5-4af8-9161-ee41c8b65a79", "symbol": "4978", "name": "ReproCELL Incorporated", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Price to sales forward of ReproCELL Inc. \u2013 TSE:4978", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbVVOWFZBZDJ1WUkxRzh2a1FTMFJtbDNqQXNvQ2V0VEFta2F5d3NFcFNVLUxSYi0xcGZvN3FaMndSREtkYlZOS0JXRVlELXhybFZVNVROX2FsWUZSMGlSOEFsNE1yUEttWmxHQkxzOXdOUHlEYkFuYnlXcGJFNkp6bTVFMUwxX3NlQnQtQTRuaDFQQkYxbXFxa2dn?oc=5", "source_name": "TradingView", "published_at": "2026-06-29T05:31:58+00:00", "published_display": "29 Jun 2026 05:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal\u00ae for Spinocerebellar Ataxia (SCA3 and SCA6)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswJBVV95cUxNY1lOTmFncXNEamVqdkZmUHJSbHhmTXo5NEJ0RXdUdmVsN0VlN3Vwc3RkWjRJNGR1TTNDOUczZDZPSjRBNDI5RW14UWNwZmJldWpKVmpBY3Nvak9paEFsUkJ1VEhrcXVVREg5QXgyeFRsXy0tVklsWS1fMzZEdlZMOEZ6YVI1aUVVR05mOWNKT0pJbE9QMDhsNzZaR3dCM0VlOGE2amhlLTJlSGQtOUhfaUdWazM0aERNQks1cjNneXY5cGxkVFBXY0p2Z182cFo1S3ZLQjZEMXB5NmgtYmZiR2RmQUE4WkFWSkt0b0h2T1N3VmE0WWhwYm4wWmxHN215ZUJSdGxzU3AzQnVVYnFueGt6eXJSeXJ5b2w2S3NEaEc2UkM0UGxYMGZFT3QyOWhqSmhB?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL Introduces StemEdit Platform AI-Designed Genome Editors & Hypoimmune iPSC Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1tdVdPcXhYWjY2Zm5WSGdfZ3g3ZWhRYkFoTlNmd0FCQlFUWWRSa2ExR2Y2endXbHI5aEEwcy1sVGRRdC1yeUo5eWgzaDNVMHNjOUVZbFF1ZjJjOHBFMk0yeUNCa9IBaEFVX3lxTFBzN3dCdEVrSDJ6N05ya0xIaHEzamljTzRSdDZOdUR0MFZidTdMY2lDbnpRc3l6Z2J2NDdpNldtUmhvSnRQU3V1QXdrQmhwd1dEekdNSlpoam5oRGliQmNfMUw0RkZmQnNi?oc=5", "source_name": "BioInformant", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL\u2019s StemRNA\u2122 iPSC Seed Stock Clones for Seamless Translational Research", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTFBrcWpfWUh0dXZkN1lhckhCYWd5aWZEVW9faExlYjB3RHpOR2Y1cC14N29sb0QtelJ4UXBYWnpkblpMSnFQWTU5TFltSjcza2JOWV9YZWFwYktPRDJvWjlNSGM1aXI0RWFPODJ30gFwQVVfeXFMTXpSQXBPMWs3T1hkWWJTTWJycHFlb2lxYnFMSmdhQWY4WFRCY1VmdzVLejcwdDZKS3VjYmhCVDlwd2hrXzQ2dWtlaEhGNnlPaXhuNzVEcUxxMzgzVlI5U1RMRW4xbzZNUklXRUZnMXREQg?oc=5", "source_name": "BioInformant", "published_at": "2025-08-04T07:00:00+00:00", "published_display": "04 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market: Chuoh Pack surges 97.66%, Reprocell jumps 32.05% among top Nikkei gainers", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPeGF3REFYMHd0dXBTenZjNGhBd1MwbFJ0TFpNek1iRmxlZ0hLZ1RvQWRUMnU0anpXQmRjSDJOcTZkM3ZHQWJZREY2dkxwVmhtdlVUMmFGMlJmVHZ4dVUyd0lTYVN5Mmc1czFuNDEwYjRqZGtuakU1VTZ2QU90UmpkeVozTnlEeHEteHlOS1lka0lUZVZsdlI1THhYVms1ekRHcnRRYnVlUDVJUkNfOXpmSE9zTkZKclNIdU1zUGxNM1IybHJWT1FyTXNtbzc?oc=5", "source_name": "Business Upturn", "published_at": "2025-02-05T08:00:00+00:00", "published_display": "05 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market: Reprocell soars 47.17% as top gainer, NCXX Group and Yamagata Bank follow with strong gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQVm0wMmlLc2F2R01lNW0wUEd2My03c2hyM091T1J1U05acU15cmxWejNEZ3ZKd1JBampISXUyU0NWVDB4RG83LXhTaThRcklYc0NiQmJxMUpxV2dQYUc4TElucG1ORU1YWkM2WnhYajZxSzh3U1pmbVZWdk5tZGxKVHdmc19Qdzg2VlBxUG5jampkMFcyU3BhWHVseXRyWVlDQWt1bjJJMU9hRVRsOThvQ2xWOWFJYi0taUNJcDhEdlFSZEljay1TNlBldUpEN3NQam5hTlBuY2sxSFY0OF9lMnVUajEwdw?oc=5", "source_name": "Business Upturn", "published_at": "2025-02-04T08:00:00+00:00", "published_display": "04 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal\u00ae SCA in the Treatment of Spinocerebellar Ataxia in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE05Vk9xaldzZzhpZm4tT0hHMnByTGQwQjA3c2FhbE9CNXNDUWRaRkxhYnhFSm5XczRUWm9zR0FlcXh3Y1RhUkJwMVE2WUtjald2YU45eUFOb2hrU21CSWfSAWNBVV95cUxONGFyUnEyMlVjV2VFakN3QmVDRDl6ejBRb1ZRX05VbnVtMmVpZHJnNUM3WEdnRWZPM0ZnWGtVMkh0T2pHeTlJWjc1WUZwZkFEQ1Z6WXYzVXJndFFPT0p2QnVlckk?oc=5", "source_name": "BioInformant", "published_at": "2018-08-07T07:00:00+00:00", "published_display": "07 Aug 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of ReproCELL Inc. \u2013 TSE:4978", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbVVOWFZBZDJ1WUkxRzh2a1FTMFJtbDNqQXNvQ2V0VEFta2F5d3NFcFNVLUxSYi0xcGZvN3FaMndSREtkYlZOS0JXRVlELXhybFZVNVROX2FsWUZSMGlSOEFsNE1yUEttWmxHQkxzOXdOUHlEYkFuYnlXcGJFNkp6bTVFMUwxX3NlQnQtQTRuaDFQQkYxbXFxa2dn?oc=5", "source_name": "TradingView", "published_at": "2026-06-29T05:31:58+00:00", "published_display": "29 Jun 2026 05:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal\u00ae for Spinocerebellar Ataxia (SCA3 and SCA6)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswJBVV95cUxNY1lOTmFncXNEamVqdkZmUHJSbHhmTXo5NEJ0RXdUdmVsN0VlN3Vwc3RkWjRJNGR1TTNDOUczZDZPSjRBNDI5RW14UWNwZmJldWpKVmpBY3Nvak9paEFsUkJ1VEhrcXVVREg5QXgyeFRsXy0tVklsWS1fMzZEdlZMOEZ6YVI1aUVVR05mOWNKT0pJbE9QMDhsNzZaR3dCM0VlOGE2amhlLTJlSGQtOUhfaUdWazM0aERNQks1cjNneXY5cGxkVFBXY0p2Z182cFo1S3ZLQjZEMXB5NmgtYmZiR2RmQUE4WkFWSkt0b0h2T1N3VmE0WWhwYm4wWmxHN215ZUJSdGxzU3AzQnVVYnFueGt6eXJSeXJ5b2w2S3NEaEc2UkM0UGxYMGZFT3QyOWhqSmhB?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL Introduces StemEdit Platform AI-Designed Genome Editors & Hypoimmune iPSC Lines", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1tdVdPcXhYWjY2Zm5WSGdfZ3g3ZWhRYkFoTlNmd0FCQlFUWWRSa2ExR2Y2endXbHI5aEEwcy1sVGRRdC1yeUo5eWgzaDNVMHNjOUVZbFF1ZjJjOHBFMk0yeUNCa9IBaEFVX3lxTFBzN3dCdEVrSDJ6N05ya0xIaHEzamljTzRSdDZOdUR0MFZidTdMY2lDbnpRc3l6Z2J2NDdpNldtUmhvSnRQU3V1QXdrQmhwd1dEekdNSlpoam5oRGliQmNfMUw0RkZmQnNi?oc=5", "source_name": "BioInformant", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPROCELL\u2019s StemRNA\u2122 iPSC Seed Stock Clones for Seamless Translational Research", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTFBrcWpfWUh0dXZkN1lhckhCYWd5aWZEVW9faExlYjB3RHpOR2Y1cC14N29sb0QtelJ4UXBYWnpkblpMSnFQWTU5TFltSjcza2JOWV9YZWFwYktPRDJvWjlNSGM1aXI0RWFPODJ30gFwQVVfeXFMTXpSQXBPMWs3T1hkWWJTTWJycHFlb2lxYnFMSmdhQWY4WFRCY1VmdzVLejcwdDZKS3VjYmhCVDlwd2hrXzQ2dWtlaEhGNnlPaXhuNzVEcUxxMzgzVlI5U1RMRW4xbzZNUklXRUZnMXREQg?oc=5", "source_name": "BioInformant", "published_at": "2025-08-04T07:00:00+00:00", "published_display": "04 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market: Chuoh Pack surges 97.66%, Reprocell jumps 32.05% among top Nikkei gainers", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPeGF3REFYMHd0dXBTenZjNGhBd1MwbFJ0TFpNek1iRmxlZ0hLZ1RvQWRUMnU0anpXQmRjSDJOcTZkM3ZHQWJZREY2dkxwVmhtdlVUMmFGMlJmVHZ4dVUyd0lTYVN5Mmc1czFuNDEwYjRqZGtuakU1VTZ2QU90UmpkeVozTnlEeHEteHlOS1lka0lUZVZsdlI1THhYVms1ekRHcnRRYnVlUDVJUkNfOXpmSE9zTkZKclNIdU1zUGxNM1IybHJWT1FyTXNtbzc?oc=5", "source_name": "Business Upturn", "published_at": "2025-02-05T08:00:00+00:00", "published_display": "05 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock market: Reprocell soars 47.17% as top gainer, NCXX Group and Yamagata Bank follow with strong gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQVm0wMmlLc2F2R01lNW0wUEd2My03c2hyM091T1J1U05acU15cmxWejNEZ3ZKd1JBampISXUyU0NWVDB4RG83LXhTaThRcklYc0NiQmJxMUpxV2dQYUc4TElucG1ORU1YWkM2WnhYajZxSzh3U1pmbVZWdk5tZGxKVHdmc19Qdzg2VlBxUG5jampkMFcyU3BhWHVseXRyWVlDQWt1bjJJMU9hRVRsOThvQ2xWOWFJYi0taUNJcDhEdlFSZEljay1TNlBldUpEN3NQam5hTlBuY2sxSFY0OF9lMnVUajEwdw?oc=5", "source_name": "Business Upturn", "published_at": "2025-02-04T08:00:00+00:00", "published_display": "04 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal\u00ae SCA in the Treatment of Spinocerebellar Ataxia in Japan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE05Vk9xaldzZzhpZm4tT0hHMnByTGQwQjA3c2FhbE9CNXNDUWRaRkxhYnhFSm5XczRUWm9zR0FlcXh3Y1RhUkJwMVE2WUtjald2YU45eUFOb2hrU21CSWfSAWNBVV95cUxONGFyUnEyMlVjV2VFakN3QmVDRDl6ejBRb1ZRX05VbnVtMmVpZHJnNUM3WEdnRWZPM0ZnWGtVMkh0T2pHeTlJWjc1WUZwZkFEQ1Z6WXYzVXJndFFPT0p2QnVlckk?oc=5", "source_name": "BioInformant", "published_at": "2018-08-07T07:00:00+00:00", "published_display": "07 Aug 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 7, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 5, "score": 57, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 129.0, "latest_week": "2026-07-10", "one_week_move": -0.8, "four_week_move": 1.6, "twelve_week_move": -28.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.991957, "market_dynamics_buy_signal": false, "relative_strength": -42.707758, "fair_value_gap": -21.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.0458, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.8% over one week, +1.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "BioInformant", "count": 3}, {"label": "Business Upturn", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "PR Newswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Regulatory and legal", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.8% over one week, +1.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of ReproCELL Inc. \u2013 TSE:4978"}], "updated_at": "2026-07-17T15:00:00.080385+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}